| [1] |
吴 菲,林国桢,张晋昕. 我国恶性肿瘤发病现状及趋势[J].中国肿瘤,2012,21(2):81-85.
|
| [2] |
郭晓峰,杨鲲鹏,崔新征,等. EGFR、CTEN和E-cadherin在非小细胞肺癌中的表达及临床意义[J].西安交通大学学报(医学版),2014,35(3):346-351.
|
| [3] |
李新源,郭亚民,吴新民. DNA甲基化和E-cadherin基因甲基化与胃癌关系研究进展[J]. 中华肿瘤防治杂志,2014,21(12):965-968.
|
| [4] |
蔡建春,刘 棣,张海萍,等. 胃癌组织和正常胃小凹上皮中抑癌基因E-cadherin hMLH1 APC和MGMT的过甲基化[J].中华肿瘤杂志,2007,20(7):510-513.
|
| [5] |
ChaoY L,Shepard C R,Wells A.Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition[J]. Mol Cancer,2010,9(1): 179.
|
| [6] |
谭米多,黄 果,谢长军,等. E-cadherin和Bcl-2在乳腺癌中的表达及其临床意义[J]. 肿瘤药学,2012,2(6):422-427.
|
| [7] |
申思宁,李 印,王家祥,等. E-cadherin和β-catenin在食管鳞癌组织中的表达及其临床病理学意义[J].中国癌症杂志,2010,20(6):427-430.
|
| [8] |
林 路,赵卫东,何 玉,等. E-cadherin,β-catenin,N-cadherin在卵巢浆液性癌中的表达及意义[J].中国组织化学与细胞化学杂志,2015,24(1):95-100.
|
| [9] |
任宏政,赵 卫,陈芙蓉,等. Twist和E-cadherin蛋白在乳腺癌组织中的表达及意义[J].肿瘤基础与临床,2011,24(5):374-376.
|
| [10] |
钱金锋,杨其昌,谢慧君,等. 乳腺浸润性导管癌中上皮间质转化相关蛋白表达与临床病理特征和预后的关系[J].中国普外基础与临床杂志,2015,22(5):591-596.
|
| [11] |
包俊杰,吴诚义.E-cadherin及N-cadherin在乳腺癌中表达的相关性及临床意义[J].中国普通外科杂志,2010,19(11):1253-1256.
|
| [12] |
何 莲,刘 骞,冯济龙,等.Snail和E-cadherin在人乳腺癌的表达及临床意义[J].解剖科学进展,2014,20(5):404-407.
|
| [13] |
李 伟,熊正文,李宏伟,等. COX-2、VEGF和E-cad在乳腺癌组织中的表达及临床病理意义[J].中国现代普通外科进展,2010,13(10):766-771.
|
| [14] |
Xie T, Yuan X L, Yu S Y, et al. Interference of HIF-lalpha by RNA reduces the expression of matrix metalloprote inase-2 in human cervical carcinoma HeLa cells[J]. Ai Zheng,2008, 27(6): 600- 605.
|
| [15] |
田立立,王艳丽,黄 韧.肿瘤转移中E-钙粘蛋白的调控[J].中国实验动物学报,2012,20(3) : 81-84.
|
| [16] |
张琳琳,吴志浩,周清华. 上皮间质转化与肿瘤耐药[J]. 中国肺癌杂志,2013,16(1):54-57.
|
| [17] |
袁 玲,王朝霞. 上皮-间质转化与肿瘤耐药性的研究进展[J].中国肿瘤临床,2013,40(17):1068-1072.
|
| [18] |
黄迎娣,崔蕾,黄利鸣,等. 上皮间质转化与肿瘤耐药[J].东南国防医药,2014,16(6):624-628.
|
| [19] |
Jia L, Zhang S, Ye Y, et al.Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells[J].Cancer Lett,2012,326(2):176-182.
|
| [20] |
Chunhacha P,Sriuranpong V, Chanvorachote P, et al.Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells[J].Oncol Lett,2013,5(3): 1043-1047.
|
| [21] |
Eidelman S, Damsky CH, Wheelock MJ, et al.Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors[J].Am J Pathol,1989,135(1):101-110.
|
| [22] |
Hermiston ML,Wong MH, Gordon JI. Forced expression of E-cadherinherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system[J]. Genes Dev,1996,10(8):985-996.
|
| [23] |
任弘毅,王艳霞,吴 江.上皮-间质转化与肿瘤转移的相关进展[J].四川解剖学杂志,2012,20(1):27-35.
|
| [24] |
徐 娟,唐 敏,曹 亚.上皮-间质转化与肿瘤的浸润和转移[J].国际病理科学与临床杂志,2008,28(6):504-507.
|
| [25] |
张 满,特木热,郭占林. 上皮间质转化(EMT)与肺癌的关系[J].内蒙古医学杂志,2014,46(12):1472-1474.
|
| [26] |
周 骁. Livin、CD44v6、E-钙黏蛋白在非小细胞肺癌组织中的表达及意义[D].苏州大学,2008.
|
| [27] |
陈晓峰. E-cadherin和nm23与非小细胞肺癌术后淋巴结转移及预后的相关性研究[D].第二军医大学,2008.
|
| [28] |
辛国宏. COX-2和E-cad在非小细胞肺癌中的表达及意义[D].河北医科大学,2009.
|
| [29] |
刘青锋. KiSS-1和E-cadherin在非小细胞肺癌组织中的表达及意义[D].中国医科大学,2009.
|
| [30] |
Shiwu W, Lan Y, Wenqing S,et al. Expression and clinical significance of CD82/KAI1 and E-cadherin non-small cell lung cancer[J].Arch Iran Med,2012,15(11):707-712.
|
| [31] |
陆国玉,吴晓飞,周 蕾,等. CD133和CD44在胃腺癌中的表达及其与E-cadherin的关系[J].南方医科大学学报,2013,33(11):1632-1637.
|
| [32] |
陆国玉,吴晓飞,周 蕾,等. ERK1和E-cadherin在胃腺癌中的表达及其临床病理意义[J].中国组织化学与细胞化学杂志,2015,24(1):72-77.
|
| [33] |
王 渝,柯昌庶,赵 秋,等. E-cadherin,β-catenin,Cyclin D1在胃腺癌中的表达及临床意义[J].世界华人消化杂志,2007,15(4):403-407.
|
| [34] |
古 涛,张元生,牛清华. RKIP和E-cadherin在胃腺癌组织中表达及意义[J].中国医疗前沿,2012,7(3):14-15.
|
| [35] |
马 勇,吴新民,郭亚民.胃癌转移相关分子标志物的研究进展[J].现代肿瘤医学,2014,22(12):3017-3020.
|
| [36] |
李爱琳,王振宁. 胃癌转移相关分子标志物的研究进展[J].消化肿瘤杂志(电子版),2012,4(4):217-220.
|
| [37] |
Kotb A M, Hierholzer A, Kemler R. Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation[J]. Breast Cancer Res,2011,13(5):104 .
|
| [38] |
Wang D, Su L, Huang D, et al. Downregulation of E-cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR[J].Mol Cancer,2011,9(10):116.
|
| [39] |
白文林,杨永平. 肝细胞癌防治热点与策略[J].传染病信息,2012,25(5):260-263.
|
| [40] |
杨永平. 肝细胞癌防治热点与策略[J].临床肝胆病杂志,2013,29(1):1-4.
|
| [41] |
Lafaro K J,Demirjian A N,Pawlik T M.Epidemiology of hepatocellular carcinoma[J].Surg Oncol Clin N Am, 2015,24(1):1-17.
|
| [42] |
刘会春.中国原发性肝癌治疗指南解读[J].肝胆外科杂志,2013,21(1):12-14.
|
| [43] |
Zhang C H, Xu G L, Jia W D.Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance[J].J Surg Res, 2012 ,174(1):120-129.
|
| [44] |
Wu Y, Zhou B P.TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion[J].Br J Cancer, 2010,102(4):639-644.
|
| [45] |
于松宁,惠永峰,宋建军,等. 阿司匹林逆转肝癌上皮细胞间质化改变的实验研究[J]. 宁夏医学杂志,2013,35(4):289-291.
|
| [46] |
Bao Y, Feng W M, Tang C W, et al;Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization[J].Hepatogastroenterology,2012,59(117):1566-1568.
|
| [47] |
李裕明.上皮间质转化标志物在循环肿瘤细胞上表达与肝癌转移相关性研究[D].第三军医大学,2013.
|
| [48] |
黄建强,常瑞明,温立强,等. E-cadherin在肝癌组织中的表达及其对肝癌患者预后的影响[J].第三军医大学学报,2014,36(22):2301-2303.
|
| [49] |
郭晓东,孟繁平,熊 璐.肝细胞肝癌E-cadherin蛋白的表达及其对判断肝癌肝移植疗效的意义[J].现代生物医学进展,2011,11(8):1469-1471.
|
| [50] |
Song X, Han P, Liu J.Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma[J].J Mol Histol, 2015,46(4-5):347-356.
|
| [51] |
Min S, Xiaoyan X, Fanghui P.The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherinherin via Snail[J].Cancer Gene Ther,2013,20(7):379-385.
|
| [52] |
江 海,李 斌,魏远福,等. nm23和E-cadherin在食管鳞癌中的表达及临床意义[J].中国老年保健医学,2014,12(5):9-11.
|
| [53] |
谢 幸.妇产科学[M].8版.北京:人民卫生出版社,2013:321-332.
|
| [54] |
黄 娟.上皮钙粘蛋白和紧密连接蛋白-3在上皮性卵巢癌中的表达及意义[D].第二军医大学,2010.
|
| [55] |
Gofuku J, Shiozaki H, Tsujinaka T,et al.Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis[J].Am J Clin Pathol,1999,111(1):29-37.
|
| [56] |
惠起源,魏晓萍.上皮间质转化在肿瘤发生发展中的作用[J].中国肿瘤,2013,22(3):219-222.
|
| [57] |
戴维奇,徐 凌,柯爱武,等. 上皮间质转化在肿瘤发生发展中的作用[J].医药论坛杂志,2011,32(12):203-206.
|
| [58] |
陈丽倩,林 洁,席晨光,等.不同级别卵巢浆液性癌中E-cadherin和p120蛋白的表达及意义[J].现代妇产科进展,2012,21(8):585-589.
|
| [59] |
Elzagheid A,Emaetig F,Alkikhia L,et al.High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer[J]. Anticancer Res,2013,33(8): 3137-3143.
|
| [60] |
Goldhirsch A, Wood W C, Coates A S,et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J].Ann Oncol,2011,22(8):1736-1747.
|
| [61] |
Gluz O,Hofmann D, Würstlein R,et al.Genomic Profiling in Luminal Breast Cancer[J]. Breast Care (Basel),2013,8(6): 414-422.
|
| [62] |
李 伟,熊正文,李宏伟,等. COX-2、VEGF和E-cadherin在乳腺癌组织中的表达及临床病理意义[J].中国现代普通外科进展,2010,13(10):766-771.
|
| [63] |
刘彦博,钟 警,文格波.乳腺癌中E-钙黏素分子调节机制的研究进展[J].现代医药卫生,2014,30(8):1190-1192.
|
| [64] |
Fujiwara M, Horiguchi M,Mori S, et al. Histiocytoid breast carcinoma: solid variant of invasive lobular carcinoma with decreased expression of both E-cadherin and CD44 epithelial variant[J]. Pathol Int,2005,55(6): 353-359.
|
| [65] |
陈 钟,董孟华,邓 锋. PKC、P120ctn和E-cad在口腔鳞癌中的表达[J].实用口腔医学杂志,2014,30(1):61-65.
|
| [66] |
岳万远,吴 勇. 涎腺腺样囊性癌中相关抑癌基因的研究进展[J].医学综述,2013,19(18):3300-3303.
|
| [67] |
张 迪.头颈部腺样囊性癌临床表现与E-cad、Ep-CAM、NCAM、整合素αvβ6表达的关系[D].泸州医学院,2014.
|
| [68] |
李小燕,卢 可,张 志,等. E-cadherin在小肠腺癌、小肠腺瘤中的表达及其意义[J].安徽医药,2014,18(11):2112-2114.
|
| [69] |
钟宝元.大肠癌中STAT3、Twist的表达及与EMT关系的研究[J].中国医学创新,2014,11(36):33-34.
|
| [70] |
夏泽亮. Ep-cam和E-cad在胆囊癌中的表达及其与胆囊癌侵袭能力的关系[D].蚌埠医学院,2013.
|
| [71] |
李晨曦. GR和E-cad在膀胱移行细胞癌中的表达及临床意义[D].天津医科大学,2014.
|
|
|
2016, Vol. 27 
